New drug VedAryo® shows promise for IBD patients in Real-World study
NCT ID NCT07273760
First seen Jan 06, 2026 · Last updated May 01, 2026 · Updated 25 times
Summary
This study followed 150 people with inflammatory bowel disease (Crohn's disease or ulcerative colitis) who were treated with VedAryo® (vedolizumab). The goal was to see if the drug helps control symptoms and is safe over 52 weeks. Researchers measured improvements in disease activity scores and tracked any side effects. The study did not compare VedAryo® to any other treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATORY BOWEL DISEASE (IBD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dr. Ali Beheshti-Namdar Clinic
Mashhad, Razavi Khorasan Province, Iran
-
Dr. Hamid Asadzadeh Aghdaei Clinic
Tehran, Iran
-
Dr. Hassan Vossoughinia Clinic
Mashhad, Razavi Khorasan Province, Iran
-
Dr. Mahtab Shabani Clinic
Tehran, Iran
-
Dr. Mohammad-Javad Kaviani Clinic
Shiraz, Fars, Iran
-
Dr. Naser Ebrahimi Daryani Clinic
Tehran, Iran
-
Gilan Gastroenterology and Hepatology Subspecialty Clinic
Rasht, Gilan Province, Iran
-
Imam Khomeini Hospital
Tehran, Iran
-
Mehr Specialty Clinic
Tehran, Iran
-
Professor Shahram Agah Gastroenterology, Hepatology, and Endoscopy Subspecialty Clinic
Tehran, Iran
-
Shariati Hospital
Tehran, Iran
-
Taleghani Hospital
Tehran, Iran
Conditions
Explore the condition pages connected to this study.